The HSD17B13 gene variant rs72613567 (T > TA) confers protection against MASLD, alcoholic liver disease, and hepatocellular carcinoma by reducing hepatic lipid biogenesis [47,52]. Here, HSD17B13 is linked to metabolic dysfunction-associated steatotic liver disease.